Sotagliflozin - Global and China Top Players Market Share and Ranking 2023
Sotagliflozin, also known as LX4211, is an orally active and a dual SGLT1/SGLT2 inhibitor, which improves glycemic control in patients with type 2 diabetes in a randomized, placebo-controlled trial.
This report studies and analyses global Sotagliflozin status and future trends, helps the client to determine the Sotagliflozin market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Sotagliflozin, and provides market size (in Tons & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Sotagliflozin market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (Tons)
(2) Global Sotagliflozin sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (Tons)
(3) China Sotagliflozin sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (Tons)
(4) Global Sotagliflozin key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Sotagliflozin key producing regions, capacity, production, and year over year growth
(6) Sotagliflozin industry chains, upstream, midstream and downstream
According to Latest Research, the global market for Sotagliflozin should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Sotagliflozin market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Sotagliflozin market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Research Institute grew percent to account for percent of the total market sales, and Pharmaceutical grew percent.
Key Players Driving the Market:
TargetMol
Clearsynth
Taiclone Biotech
MedKoo Biosciences
AbMole BioScience
CSN Pharm
Medchemexpress
Selleck Chemical
Viatris
Sanofi
Mankind Pharma
Huikang Boyuan Chemical
Vcare Pharmatech
Prisun Pharmatech
By Product Type, the market is primarily segmented into:
Purity ≥ 98 %
Purity ≥ 99 %
By Applications, the market is segmented into:
Research Institute
Pharmaceutical
Others
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
The Report Consists of The Following Points:
Chapter 1: to describe Sotagliflozin product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Sotagliflozin market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Sotagliflozin market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Sotagliflozin, percent & CAGR, 2018-2029
Chapter 5: Sotagliflozin industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Sotagliflozin Definition
1.2 Global Sotagliflozin Market Size and Forecast
1.2.1 By Consumption Value, Global Sotagliflozin Market Size，2018-2029
1.2.2 By Sales Quantity, Global Sotagliflozin Market Size，2018-2029
1.2.3 Global Sotagliflozin Average Selling Price (ASP)，2018-2029
1.3 China Sotagliflozin Market Size and Forecast
1.3.1 By Consumption Value, China Sotagliflozin Market Size，2018-2029
1.3.2 By Sales Quantity, China Sotagliflozin Market Size，2018-2029
1.3.3 China Sotagliflozin Average Selling Price (ASP)， 2018-2029
1.4 Share of China Sotagliflozin Market with Respect to the Global Market
1.4.1 By Consumption Value, China Sotagliflozin Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China Sotagliflozin Market Share in Global, 2018-2029
1.4.3 Sotagliflozin Market Size: China VS Global, 2018-2029
1.5 Sotagliflozin Market Dynamics
1.5.1 Sotagliflozin Market Drivers
1.5.2 Sotagliflozin Market Restraints
1.5.3 Sotagliflozin Industry Trends
1.5.4 Sotagliflozin Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Sotagliflozin, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of Sotagliflozin, Global Market Share by Company, 2018-2023
2.3 Sotagliflozin Average Selling Price (ASP) by Company, 2018-2023
2.4 Global Sotagliflozin Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Sotagliflozin Concentration Ratio
2.6 Global Sotagliflozin Mergers & Acquisitions, Expansion Plans
2.7 Global Sotagliflozin Manufacturers Product Type
2.8 Head Office and Sotagliflozin Production Site of Key Manufacturer
2.9 Sotagliflozin Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Sotagliflozin, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of Sotagliflozin, China Market Share by Company, 2018-2023
3.3 China Sotagliflozin Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Sotagliflozin Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global Sotagliflozin Capacity by Region
4.3 Global Sotagliflozin Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global Sotagliflozin Production by Region, 2018-2029
4.5 Global Sotagliflozin Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Sotagliflozin Industry Chain
5.2 Sotagliflozin Upstream Analysis
5.2.1 Sotagliflozin Core Raw Materials
5.2.2 Main Manufacturers of Sotagliflozin Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Sotagliflozin Production Mode
5.6 Sotagliflozin Procurement Model
5.7 Sotagliflozin Industry Sales Model and Sales Channels
5.7.1 Sotagliflozin Sales Model
5.7.2 Sotagliflozin Typical Distributors
6 Sights by Type
6.1 Sotagliflozin Classification
6.1.1 Purity ≥ 98 %
6.1.2 Purity ≥ 99 %
6.2 By Type, Global Sotagliflozin Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Sotagliflozin Consumption Value, 2018-2029
6.4 By Type, Global Sotagliflozin Sales Quantity, 2018-2029
6.5 By Type, Global Sotagliflozin Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 Sotagliflozin Segment by Application
7.1.1 Research Institute
7.1.2 Pharmaceutical
7.1.3 Others
7.2 By Application, Global Sotagliflozin Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Sotagliflozin Consumption Value, 2018-2029
7.4 By Application, Global Sotagliflozin Sales Quantity, 2018-2029
7.5 By Application, Global Sotagliflozin Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Sotagliflozin Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global Sotagliflozin Consumption Value, 2018-2029
8.3 By Region, Global Sotagliflozin Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America Sotagliflozin & Forecasts, 2018-2029
8.4.2 By Country, North America Sotagliflozin Market Size Market Share
8.5 Europe
8.5.1 Europe Sotagliflozin Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Sotagliflozin Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Sotagliflozin Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Sotagliflozin Market Size Market Share
8.7 South America
8.7.1 South America Sotagliflozin Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Sotagliflozin Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Sotagliflozin Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global Sotagliflozin Consumption Value, 2018-2029
9.3 By Country, Global Sotagliflozin Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. Sotagliflozin Market Size, 2018-2029
9.4.2 By Type, U.S. Sotagliflozin Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Sotagliflozin Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Sotagliflozin Market Size, 2018-2029
9.5.2 By Type, Europe Sotagliflozin Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Sotagliflozin Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Sotagliflozin Market Size, 2018-2029
9.6.2 By Type, China Sotagliflozin Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Sotagliflozin Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Sotagliflozin Market Size, 2018-2029
9.7.2 By Type, Japan Sotagliflozin Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Sotagliflozin Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Sotagliflozin Market Size, 2018-2029
9.8.2 By Type, South Korea Sotagliflozin Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Sotagliflozin Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Sotagliflozin Market Size, 2018-2029
9.9.2 By Type, Southeast Asia Sotagliflozin Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Sotagliflozin Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Sotagliflozin Market Size, 2018-2029
9.10.2 By Type, India Sotagliflozin Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Sotagliflozin Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Sotagliflozin Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa Sotagliflozin Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Sotagliflozin Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 TargetMol
10.1.1 TargetMol Company Information, Head Office, Market Area, and Industry Position
10.1.2 TargetMol Sotagliflozin Models, Specifications, and Application
10.1.3 TargetMol Sotagliflozin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 TargetMol Company Profile and Main Business
10.1.5 TargetMol Recent Developments
10.2 Clearsynth
10.2.1 Clearsynth Company Information, Head Office, Market Area, and Industry Position
10.2.2 Clearsynth Sotagliflozin Models, Specifications, and Application
10.2.3 Clearsynth Sotagliflozin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Clearsynth Company Profile and Main Business
10.2.5 Clearsynth Recent Developments
10.3 Taiclone Biotech
10.3.1 Taiclone Biotech Company Information, Head Office, Market Area, and Industry Position
10.3.2 Taiclone Biotech Sotagliflozin Models, Specifications, and Application
10.3.3 Taiclone Biotech Sotagliflozin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Taiclone Biotech Company Profile and Main Business
10.3.5 Taiclone Biotech Recent Developments
10.4 MedKoo Biosciences
10.4.1 MedKoo Biosciences Company Information, Head Office, Market Area, and Industry Position
10.4.2 MedKoo Biosciences Sotagliflozin Models, Specifications, and Application
10.4.3 MedKoo Biosciences Sotagliflozin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 MedKoo Biosciences Company Profile and Main Business
10.4.5 MedKoo Biosciences Recent Developments
10.5 AbMole BioScience
10.5.1 AbMole BioScience Company Information, Head Office, Market Area, and Industry Position
10.5.2 AbMole BioScience Sotagliflozin Models, Specifications, and Application
10.5.3 AbMole BioScience Sotagliflozin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 AbMole BioScience Company Profile and Main Business
10.5.5 AbMole BioScience Recent Developments
10.6 CSN Pharm
10.6.1 CSN Pharm Company Information, Head Office, Market Area, and Industry Position
10.6.2 CSN Pharm Sotagliflozin Models, Specifications, and Application
10.6.3 CSN Pharm Sotagliflozin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 CSN Pharm Company Profile and Main Business
10.6.5 CSN Pharm Recent Developments
10.7 Medchemexpress
10.7.1 Medchemexpress Company Information, Head Office, Market Area, and Industry Position
10.7.2 Medchemexpress Sotagliflozin Models, Specifications, and Application
10.7.3 Medchemexpress Sotagliflozin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Medchemexpress Company Profile and Main Business
10.7.5 Medchemexpress Recent Developments
10.8 Selleck Chemical
10.8.1 Selleck Chemical Company Information, Head Office, Market Area, and Industry Position
10.8.2 Selleck Chemical Sotagliflozin Models, Specifications, and Application
10.8.3 Selleck Chemical Sotagliflozin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Selleck Chemical Company Profile and Main Business
10.8.5 Selleck Chemical Recent Developments
10.9 Viatris
10.9.1 Viatris Company Information, Head Office, Market Area, and Industry Position
10.9.2 Viatris Sotagliflozin Models, Specifications, and Application
10.9.3 Viatris Sotagliflozin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Viatris Company Profile and Main Business
10.9.5 Viatris Recent Developments
10.10 Sanofi
10.10.1 Sanofi Company Information, Head Office, Market Area, and Industry Position
10.10.2 Sanofi Sotagliflozin Models, Specifications, and Application
10.10.3 Sanofi Sotagliflozin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Sanofi Company Profile and Main Business
10.10.5 Sanofi Recent Developments
10.11 Mankind Pharma
10.11.1 Mankind Pharma Company Information, Head Office, Market Area, and Industry Position
10.11.2 Mankind Pharma Sotagliflozin Models, Specifications, and Application
10.11.3 Mankind Pharma Sotagliflozin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Mankind Pharma Company Profile and Main Business
10.11.5 Mankind Pharma Recent Developments
10.12 Huikang Boyuan Chemical
10.12.1 Huikang Boyuan Chemical Company Information, Head Office, Market Area, and Industry Position
10.12.2 Huikang Boyuan Chemical Sotagliflozin Models, Specifications, and Application
10.12.3 Huikang Boyuan Chemical Sotagliflozin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Huikang Boyuan Chemical Company Profile and Main Business
10.12.5 Huikang Boyuan Chemical Recent Developments
10.13 Vcare Pharmatech
10.13.1 Vcare Pharmatech Company Information, Head Office, Market Area, and Industry Position
10.13.2 Vcare Pharmatech Sotagliflozin Models, Specifications, and Application
10.13.3 Vcare Pharmatech Sotagliflozin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Vcare Pharmatech Company Profile and Main Business
10.13.5 Vcare Pharmatech Recent Developments
10.14 Prisun Pharmatech
10.14.1 Prisun Pharmatech Company Information, Head Office, Market Area, and Industry Position
10.14.2 Prisun Pharmatech Sotagliflozin Models, Specifications, and Application
10.14.3 Prisun Pharmatech Sotagliflozin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Prisun Pharmatech Company Profile and Main Business
10.14.5 Prisun Pharmatech Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Sotagliflozin Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Sotagliflozin Market Restraints
Table 3. Sotagliflozin Market Trends
Table 4. Sotagliflozin Industry Policy
Table 5. Global Sotagliflozin Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Sotagliflozin Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Sotagliflozin Sales Quantity by Company, (2018-2023) & (Tons), Ranked Based on Sales in 2022
Table 8. Global Sotagliflozin Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Sotagliflozin Average Selling Price (ASP) by Company, (2018-2023) & (US$/Ton)
Table 10. Global Sotagliflozin Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Sotagliflozin Mergers & Acquisitions, Expansion Plans
Table 12. Global Sotagliflozin Manufacturers Product Type
Table 13. Head Office and Sotagliflozin Production Site of Key Manufacturer
Table 14. Sotagliflozin Capacity of Major Manufacturers and Future Plan
Table 15. China Sotagliflozin Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Sotagliflozin Sales Quantity by Company, (2018-2023) & (Tons), Ranked Based on Sales in 2022
Table 17. China Sotagliflozin Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Sotagliflozin Production & Forecast by Region, 2018 VS 2022 VS 2029, (Tons)
Table 19. Global Sotagliflozin Production by Region, 2018-2023, (Tons)
Table 20. Global Sotagliflozin Production Forecast by Region, 2024-2029, (Tons)
Table 21. Global Key Players of Sotagliflozin Upstream (Raw Materials)
Table 22. Global Sotagliflozin Typical Customers
Table 23. Sotagliflozin Typical Distributors
Table 24. By Type, Global Sotagliflozin Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Sotagliflozin Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Sotagliflozin Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Sotagliflozin Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Sotagliflozin Sales Quantity, 2018-2029, (Tons)
Table 29. By Country, Global Sotagliflozin Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Sotagliflozin Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Sotagliflozin Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Sotagliflozin Sales Quantity, 2018-2029, (Tons)
Table 33. By Country, Global Sotagliflozin Sales Quantity Market Share, 2018-2029
Table 34. TargetMol Company Information, Head Office, Market Area, and Industry Position
Table 35. TargetMol Sotagliflozin Models, Specifications, and Application
Table 36. TargetMol Sotagliflozin Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 37. TargetMol Company Profile and Main Business
Table 38. TargetMol Recent Developments
Table 39. Clearsynth Company Information, Head Office, Market Area, and Industry Position
Table 40. Clearsynth Sotagliflozin Models, Specifications, and Application
Table 41. Clearsynth Sotagliflozin Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 42. Clearsynth Company Profile and Main Business
Table 43. Clearsynth Recent Developments
Table 44. Taiclone Biotech Company Information, Head Office, Market Area, and Industry Position
Table 45. Taiclone Biotech Sotagliflozin Models, Specifications, and Application
Table 46. Taiclone Biotech Sotagliflozin Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 47. Taiclone Biotech Company Profile and Main Business
Table 48. Taiclone Biotech Recent Developments
Table 49. MedKoo Biosciences Company Information, Head Office, Market Area, and Industry Position
Table 50. MedKoo Biosciences Sotagliflozin Models, Specifications, and Application
Table 51. MedKoo Biosciences Sotagliflozin Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 52. MedKoo Biosciences Company Profile and Main Business
Table 53. MedKoo Biosciences Recent Developments
Table 54. AbMole BioScience Company Information, Head Office, Market Area, and Industry Position
Table 55. AbMole BioScience Sotagliflozin Models, Specifications, and Application
Table 56. AbMole BioScience Sotagliflozin Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 57. AbMole BioScience Company Profile and Main Business
Table 58. AbMole BioScience Recent Developments
Table 59. CSN Pharm Company Information, Head Office, Market Area, and Industry Position
Table 60. CSN Pharm Sotagliflozin Models, Specifications, and Application
Table 61. CSN Pharm Sotagliflozin Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 62. CSN Pharm Company Profile and Main Business
Table 63. CSN Pharm Recent Developments
Table 64. Medchemexpress Company Information, Head Office, Market Area, and Industry Position
Table 65. Medchemexpress Sotagliflozin Models, Specifications, and Application
Table 66. Medchemexpress Sotagliflozin Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 67. Medchemexpress Company Profile and Main Business
Table 68. Medchemexpress Recent Developments
Table 69. Selleck Chemical Company Information, Head Office, Market Area, and Industry Position
Table 70. Selleck Chemical Sotagliflozin Models, Specifications, and Application
Table 71. Selleck Chemical Sotagliflozin Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 72. Selleck Chemical Company Profile and Main Business
Table 73. Selleck Chemical Recent Developments
Table 74. Viatris Company Information, Head Office, Market Area, and Industry Position
Table 75. Viatris Sotagliflozin Models, Specifications, and Application
Table 76. Viatris Sotagliflozin Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 77. Viatris Company Profile and Main Business
Table 78. Viatris Recent Developments
Table 79. Sanofi Company Information, Head Office, Market Area, and Industry Position
Table 80. Sanofi Sotagliflozin Models, Specifications, and Application
Table 81. Sanofi Sotagliflozin Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 82. Sanofi Company Profile and Main Business
Table 83. Sanofi Recent Developments
Table 84. Mankind Pharma Company Information, Head Office, Market Area, and Industry Position
Table 85. Mankind Pharma Sotagliflozin Models, Specifications, and Application
Table 86. Mankind Pharma Sotagliflozin Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 87. Mankind Pharma Company Profile and Main Business
Table 88. Mankind Pharma Recent Developments
Table 89. Huikang Boyuan Chemical Company Information, Head Office, Market Area, and Industry Position
Table 90. Huikang Boyuan Chemical Sotagliflozin Models, Specifications, and Application
Table 91. Huikang Boyuan Chemical Sotagliflozin Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 92. Huikang Boyuan Chemical Company Profile and Main Business
Table 93. Huikang Boyuan Chemical Recent Developments
Table 94. Vcare Pharmatech Company Information, Head Office, Market Area, and Industry Position
Table 95. Vcare Pharmatech Sotagliflozin Models, Specifications, and Application
Table 96. Vcare Pharmatech Sotagliflozin Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 97. Vcare Pharmatech Company Profile and Main Business
Table 98. Vcare Pharmatech Recent Developments
Table 99. Prisun Pharmatech Company Information, Head Office, Market Area, and Industry Position
Table 100. Prisun Pharmatech Sotagliflozin Models, Specifications, and Application
Table 101. Prisun Pharmatech Sotagliflozin Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 102. Prisun Pharmatech Company Profile and Main Business
Table 103. Prisun Pharmatech Recent Developments
List of Figures
Figure 1. Sotagliflozin Picture
Figure 2. Global Sotagliflozin Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Sotagliflozin Sales Quantity, (Tons) & (2018-2029)
Figure 4. Global Sotagliflozin Average Selling Price (ASP), (2018-2029) & (US$/Ton)
Figure 5. China Sotagliflozin Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Sotagliflozin Sales Quantity (Tons) & (2018-2029)
Figure 7. China Sotagliflozin Average Selling Price (ASP), (US$/Ton) & (2018-2029)
Figure 8. By Consumption Value, China Sotagliflozin Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Sotagliflozin Market Share of Global, 2018-2029
Figure 10. Global Sotagliflozin Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Sotagliflozin Key Participants, Market Share, 2022
Figure 12. Global Sotagliflozin Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Sotagliflozin Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Sotagliflozin Production Market Share & Forecast by Region, 2018-2029
Figure 15. Sotagliflozin Industry Chain
Figure 16. Sotagliflozin Procurement Model
Figure 17. Sotagliflozin Sales Model
Figure 18. Sotagliflozin Sales Channels, Direct Sales, and Distribution
Figure 19. Purity ≥ 98 %
Figure 20. Purity ≥ 99 %
Figure 21. By Type, Global Sotagliflozin Consumption Value, 2018-2029, US$ Million
Figure 22. By Type, Global Sotagliflozin Consumption Value Market Share, 2018-2029
Figure 23. By Type, Global Sotagliflozin Sales Quantity, 2018-2029, (Tons)
Figure 24. By Type, Global Sotagliflozin Sales Quantity Market Share, 2018-2029
Figure 25. By Type, Global Sotagliflozin Average Selling Price (ASP), 2018-2029, (US$/Ton)
Figure 26. Research Institute
Figure 27. Pharmaceutical
Figure 28. Others
Figure 29. By Application, Global Sotagliflozin Consumption Value, 2018-2029, US$ Million
Figure 30. By Application, Global Sotagliflozin Consumption Value Market Share, 2018-2029
Figure 31. By Application, Global Sotagliflozin Sales Quantity, 2018-2029, (Tons)
Figure 32. By Application, Global Sotagliflozin Sales Quantity Market Share, 2018-2029
Figure 33. By Application, Global Sotagliflozin Average Selling Price (ASP), 2018-2029, (US$/Ton)
Figure 34. By Region, Global Sotagliflozin Consumption Value Market Share, 2018-2029
Figure 35. By Region, Global Sotagliflozin Sales Quantity Market Share, 2018-2029
Figure 36. North America Sotagliflozin Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 37. By Country, North America Sotagliflozin Consumption Value Market Share, 2022
Figure 38. Europe Sotagliflozin Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 39. By Country, Europe Sotagliflozin Consumption Value Market Share, 2022
Figure 40. Asia Pacific Sotagliflozin Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 41. By Country/Region, Asia Pacific Sotagliflozin Consumption Value Market Share, 2022
Figure 42. South America Sotagliflozin Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 43. By Country, South America Sotagliflozin Consumption Value Market Share, 2022
Figure 44. Middle East & Africa Sotagliflozin Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 45. U.S. Sotagliflozin Sales Quantity, 2018-2029, (Tons)
Figure 46. By Type, U.S. Sotagliflozin Sales Quantity Market Share, 2022 VS 2029
Figure 47. By Application, U.S. Sotagliflozin Sales Quantity Market Share, 2022 VS 2029
Figure 48. Europe Sotagliflozin Sales Quantity, 2018-2029, (Tons)
Figure 49. By Type, Europe Sotagliflozin Sales Quantity Market Share, 2022 VS 2029
Figure 50. By Application, Europe Sotagliflozin Sales Quantity Market Share, 2022 VS 2029
Figure 51. China Sotagliflozin Sales Quantity, 2018-2029, (Tons)
Figure 52. By Type, China Sotagliflozin Sales Quantity Market Share, 2022 VS 2029
Figure 53. By Application, China Sotagliflozin Sales Quantity Market Share, 2022 VS 2029
Figure 54. Japan Sotagliflozin Sales Quantity, 2018-2029, (Tons)
Figure 55. By Type, Japan Sotagliflozin Sales Quantity Market Share, 2022 VS 2029
Figure 56. By Application, Japan Sotagliflozin Sales Quantity Market Share, 2022 VS 2029
Figure 57. South Korea Sotagliflozin Sales Quantity, 2018-2029, (Tons)
Figure 58. By Type, South Korea Sotagliflozin Sales Quantity Market Share, 2022 VS 2029
Figure 59. By Application, South Korea Sotagliflozin Sales Quantity Market Share, 2022 VS 2029
Figure 60. Southeast Asia Sotagliflozin Sales Quantity, 2018-2029, (Tons)
Figure 61. By Type, Southeast Asia Sotagliflozin Sales Quantity Market Share, 2022 VS 2029
Figure 62. By Application, Southeast Asia Sotagliflozin Sales Quantity Market Share, 2022 VS 2029
Figure 63. India Sotagliflozin Sales Quantity, 2018-2029, (Tons)
Figure 64. By Type, India Sotagliflozin Sales Quantity Market Share, 2022 VS 2029
Figure 65. By Application, India Sotagliflozin Sales Quantity Market Share, 2022 VS 2029
Figure 66. Middle East & Africa Sotagliflozin Sales Quantity, 2018-2029, (Tons)
Figure 67. By Type, Middle East & Africa Sotagliflozin Sales Quantity Market Share, 2022 VS 2029
Figure 68. By Application, Middle East & Africa Sotagliflozin Sales Quantity Market Share, 2022 VS 2029
Figure 69. Research Methodology
Figure 70. Breakdown of Primary Interviews
Figure 71. Bottom-up and Top-down Approaches
Figure 72. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|